Home » Topics » Disease categories and therapies » Urology

Urology
RSS

twoXAR collaborates with Mount Sinai researchers in diabetic nephropathy

Oct. 5, 2016

Peloton Therapeutics describes HIF-2alpha inhibitors

Sep. 26, 2016

Astellas Pharma and Kotobuki Pharmaceutical patent agents for nocturia

Sep. 23, 2016

Regulus begins phase II trial of RG-012 in Alport syndrome

Sep. 22, 2016

Bayer and Evotec establish 5-year research partnership in kidney disease

Sep. 22, 2016

Promising phase II topline results for sparsentan in focal segmental glomerulosclerosis

Sep. 8, 2016

Aquinox initiates phase III study of AQX-1125 for interstitial cystitis/bladder pain syndrome

Sep. 7, 2016

Nymox's fexapotide shows clinically meaningful benefits in BPH

Aug. 31, 2016

Nymox Pharmaceutical announces positive results on fexapotide phase III trial

Aug. 25, 2016

Aurinia reports promising findings from phase IIb study of voclosporin in active lupus nephritis

Aug. 16, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Selection Therapeutics identifies new Kv1.3 blockers
BioWorld Science
Selection Therapeutics GmbH has discovered new potassium voltage-gated channel subfamily A member 3 (KCNA3; Kv1.3) blockers potentially useful for the treatment...
Ignis Therapeutics synthesizes new muscarinic M4 receptor PAMs
BioWorld Science
Ignis Therapeutics (Suzhou) Co. Ltd. has patented new muscarinic M4 receptor positive allosteric modulators (PAMs) potentially useful for the treatment of...